Loading
Life sciences · Journal article
Experimed · August 12, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a dose-response study of verbascoside in cultured 3T3-L1 adipocytes showing that the 100 μM dose reduced lipid accumulation, lowered DNA damage, and improved oxidative stress markers (increased TAS, decreased TOS and OSI), while the 50 μM dose increased DNA damage. The findings are mechanistic and exploratory, derived from a single cell line without in vivo validation or clinical translation.
In vitro dose-response study in cultured cells. 3T3-L1 mouse adipocytes (in vitro culture); no human or animal subjects.. Intervention: Verbascoside 50 μM (V50) or 100 μM (V100). Compared with: Control group (untreated mature adipocytes).
V100 reduced lipid accumulation compared with control group V50 increased DNA damage (tail intensity and moment) whereas V100 significantly lowered it compared to V50 V100 improved oxidative stress markers: increased TAS, decreased TOS, and decreased OSI; V50 had no significant effect on these parameters
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This is exploratory mechanistic work and does not support clinical use; dose-dependent effects noted in cells may not translate to organisms. Further molecular and preclinical studies are explicitly needed before any metabolic disorder application.
In vitro mechanistic study in cultured adipocytes with no animal or human data, surrogate endpoints only, and authors acknowledge need for further molecular studies.
As stated by the source record.
Quoted from the source exactly as published.
This is exploratory mechanistic work and does not support clinical use; dose-dependent effects noted in cells may not translate to organisms. Further molecular and preclinical studies are explicitly needed before any metabolic disorder application.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Objective: Obesity involves excessive lipid accumulation in adipose tissue, triggering oxidative stress and DNA damage. This study evaluated the effects of verbascoside doses (50 μM: V50 and 100 μM: V100) on DNA damage and oxidative stress in mature adipocytes.Materials and Methods: 3T3-L1 cells were differentiated into mature adipocytes and treated with V50 or V100. Oil Red O staining quantified the lipid accumulation. DNA damage was evaluated using the Comet assay. We assessed oxidative stress by calculating the oxidative stress index (OSI) based on total oxidant status (TOS) and total antioxidant status (TAS) measurements.Results: V100 reduced lipid accumulation compared with the control group. Furthermore, while V50 increased DNA damage (tail intensity and moment), V100 significantly lowered it compared to V50. Additionally, V100 improved oxidative stress markers (increased TAS, decreased TOS, and OSI), whereas V50 had no significant effect on these parameters.Conclusion: Verbascoside showed dose-dependent effects on mature adipocytes. While V50 increased DNA damage independently of oxidative stress, V100 improved oxidative status and reduced DNA damage. These findings demonstrate that at appropriate doses, verbascoside is a candidate for preventing metabolic disorders, though further molecular studies are needed.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.